financetom
Business
financetom
/
Business
/
Aurora Innovation Insider Sold Shares Worth $27,455,944, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Aurora Innovation Insider Sold Shares Worth $27,455,944, According to a Recent SEC Filing
Nov 9, 2024 1:35 PM

05:25 PM EST, 11/08/2024 (MT Newswires) -- Reid Hoffman, Director, on November 06, 2024, sold 4,929,713 shares in Aurora Innovation ( AUR ) for $27,455,944. Following the Form 4 filing with the SEC, Hoffman has control over a total of 9,154,991 shares of the company, with 286,247 shares held directly and 8,868,744 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1828108/000182810824000145/xslF345X05/wk-form4_1731103992.xml

Price: 5.19, Change: +0.01, Percent Change: +0.19

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tamarack Valley Energy Q3 Earnings Up, but Misses Forecast; Corporate Guidance and Dividend Increase
Tamarack Valley Energy Q3 Earnings Up, but Misses Forecast; Corporate Guidance and Dividend Increase
Oct 31, 2024
06:32 AM EDT, 10/31/2024 (MT Newswires) -- Tamarack Valley Energy ( TNEYF ) on Thursday reported an increase in third quarter earnings, even if it missed forecasts, as strong production in the quarter prompted it to increase its dividend. Third-quarter earning per share basic and diluted rose to $0.17 compared with $0.02 a year earlier. The consensus forecast at Capital...
Merck third quarter better than expected, but Gardasil sales sag in China again
Merck third quarter better than expected, but Gardasil sales sag in China again
Oct 31, 2024
Oct 31 (Reuters) - Merck & Co ( MRK ) posted higher-than-expected third-quarter earnings on Thursday on strong sales of its blockbuster cancer treatment Keytruda, but the U.S. drugmaker also flagged a second straight quarter of weak demand for its Gardasil vaccine in China. Gardasil, which prevents cancers caused by the human papillomavirus, has been one of Merck's ( MRK...
Merck third quarter better than expected, but Gardasil sales sag in China again
Merck third quarter better than expected, but Gardasil sales sag in China again
Oct 31, 2024
(Reuters) - Merck & Co ( MRK ) posted higher-than-expected third-quarter earnings on Thursday on strong sales of its blockbuster cancer treatment Keytruda, but the U.S. drugmaker also flagged a second straight quarter of weak demand for its Gardasil vaccine in China. Gardasil, which prevents cancers caused by the human papillomavirus, has been one of Merck's ( MRK ) top...
HF Sinclair posts third quarter loss
HF Sinclair posts third quarter loss
Oct 31, 2024
Oct 31 (Reuters) - Refiner HF Sinclair reported a loss in third-quarter profit on Thursday, hurt by a slump in margins, especially in the West and Mid-Continent regions, due to an oversupply. The Dallas-based company posted a loss of $75.9 million, or 40 cents per share, in the quarter ending September, compared with net income of $790.9 million, or $4.23...
Copyright 2023-2026 - www.financetom.com All Rights Reserved